scispace - formally typeset
C

Carolin Reiser-Erkan

Researcher at Technische Universität München

Publications -  14
Citations -  1554

Carolin Reiser-Erkan is an academic researcher from Technische Universität München. The author has contributed to research in topics: Pancreatic cancer & Cancer. The author has an hindex of 11, co-authored 14 publications receiving 1383 citations.

Papers
More filters
Journal ArticleDOI

The Activated Stroma Index Is a Novel and Independent Prognostic Marker in Pancreatic Ductal Adenocarcinoma

TL;DR: The activated stroma index (ASI) is a novel independent prognostic marker in PDAC in cases undergoing surgery and highlights the impact of the microenvironment in cancer progression and on patient survival.
Journal ArticleDOI

Cancer-stellate cell interactions perpetuate the hypoxia-fibrosis cycle in pancreatic ductal adenocarcinoma.

TL;DR: Although PSCs are the dominant producers of VEGF and increase endothelial cell growth in vitro, in the peritumoral stroma, they contribute to the fibrotic/hypoxic milieu through abnormal extracellular matrix deposition and by amplifying endostatin production of cancer cells.
Journal Article

Tumor microenvironment and progression of pancreatic cancer.

TL;DR: It has recently been shown that the activated stroma of pancreatic cancer is an independent prognostic marker with an impact on patient survival as much as the lymph node status of the cancer.
Journal ArticleDOI

Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma.

TL;DR: Ex expression of Pim-1 mRNA and protein increased significantly in pancreatic malignancies compared to benign, inflammatory and pre-malignant conditions and Hypoxia is a novel inducer of PIM-1 expression.